Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Trump Moves to Put New Tariffs on Computer Chips and Drugsnews2025-04-14T23:03:07+00:00April 14th, 2025|The New York Times|
BioNTech-backed ADC maker DualityBio plans Hong Kong IPOnews2025-04-14T19:23:17+00:00April 14th, 2025|Endpoints News|
US commission calls for $15B biotech investment to blunt Chinanews2025-04-08T04:01:22+00:00April 8th, 2025|Endpoints News|
ADC startup DualityBio seeks Hong Kong IPO amid precarious marketnews2025-04-07T11:35:57+00:00April 7th, 2025|Endpoints News|
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Fundingnews2025-04-06T09:01:05+00:00April 6th, 2025|The New York Times|
China’s retaliatory tariffs on US could mean more headwinds for drugmakersnews2025-04-04T17:25:01+00:00April 4th, 2025|Endpoints News|
F-star management takes company private, two years after $161M cash exit to Sino’s invoXnews2025-04-04T02:01:44+00:00April 4th, 2025|Endpoints News|
WuXi Biologics’ licensing deals help offset Biosecure threat in the USnews2025-03-25T15:11:03+00:00March 25th, 2025|Endpoints News|
Merck and Hengrui strike $2B deal for Lipoprotein(a) drugnews2025-03-25T10:30:41+00:00March 25th, 2025|Endpoints News|
